Patents by Inventor Beena Koshy

Beena Koshy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Haplotype Markers And Methods Of Using The Same To Determine Response To Treatment
    Publication number: 20080020383
    Abstract: The present invention relates to methods for diagnosing or predicting responsiveness to treatment, such as Alefacept, by determining the presence of a nucleotide at one or more polymorphic sites within a haplotype marker. The present invention identifies multiple haplotypes that are associated with response to Alefacept. The haplotype markers identified by the present invention and methods of the invention can be particularly useful for diagnosing or predicting susceptibility to skin diseases, such as Psoriasis.
    Type: Application
    Filed: May 4, 2005
    Publication date: January 24, 2008
    Applicant: GENAISSANCE PHARMACEUTICALS, Inc.
    Inventors: Beena Koshy, Bradley Dain, Madan Anant, Ping Zhan
  • Haplotypes of the CXCR4 gene
    Publication number: 20030207281
    Abstract: Novel genetic variants of the Chemokine Receptor 4 (CXCR4) gene are described. Various genotypes, haplotypes, and haplotype pairs that exist in the general United States population are disclosed for the CXCR4 gene. Compositions and methods for haplotyping and/or genotyping the CXCR4 gene in an individual are also disclosed. Polynucleotides defined by the haplotypes disclosed herein are also described.
    Type: Application
    Filed: May 30, 2002
    Publication date: November 6, 2003
    Inventors: Steven C. Bentivegna, Karyn M. Bieglecki, Beena Koshy, Glen Monroe, Eileen Rounds
  • Haplotypes of the TACR2 gene
    Publication number: 20030198969
    Abstract: Novel genetic variants of the Tachykinin Receptor 2 (TACR2) gene are described. Various genotypes, haplotypes, and haplotype pairs that exist in the general United States population are disclosed for the TACR2 gene. Compositions and methods for haplotyping and/or genotyping the TACR2 gene in an individual are also disclosed. Polynucleotides defined by the haplotypes disclosed herein are also described.
    Type: Application
    Filed: May 30, 2002
    Publication date: October 23, 2003
    Inventors: Karyn M. Bieglecki, Gina-Marie Cappola, Beena Koshy, Glen Monroe
  • Haplotypes of the SLC26A2 gene
    Publication number: 20030194728
    Abstract: Novel genetic variants of the Solute Carrier Family 26, Member 2 (SLC26A2) gene are described. Various genotypes, haplotypes, and haplotype pairs that exist in the general United States population are disclosed for the SLC26A2 gene. Compositions and methods for haplotyping and/or genotyping the SLC26A2 gene in an individual are also disclosed. Polynucleotides defined by the haplotypes disclosed herein are also described.
    Type: Application
    Filed: December 23, 2002
    Publication date: October 16, 2003
    Inventors: Stefanie E. Kliem, Beena Koshy, Debra A. Tanguay
  • Haplotypes of the AGTR1 gene
    Patent number: 6521747
    Abstract: Novel genetic variants of the Angiotensin Receptor 1 (AGTR1) gene are described. Various genotypes, haplotypes, and haplotype pairs that exist in the general United States population are disclosed for the AGTR1 gene. Compositions and methods for haplotyping and/or genotyping the AGTR1 gene in an individual are also disclosed. Polynucleotides defined by the sequence of the haplotypes disclosed herein are also described.
    Type: Grant
    Filed: May 30, 2001
    Date of Patent: February 18, 2003
    Assignee: Genaissance Pharmaceuticals, Inc.
    Inventors: Alison E. Anastasio, Kevin Finkel, Beena Koshy, Helen Lee
  • Haplotypes of the AGTR1 gene
    Publication number: 20020182605
    Abstract: Novel genetic variants of the Angiotensin Receptor 1 (AGTR1) gene are described. Various genotypes, haplotypes, and haplotype pairs that exist in the general United States population are disclosed for the AGTR1 gene. Compositions and methods for haplotyping and/or genotyping the AGTR1 gene in an individual are also disclosed. Polynucleotides defined by the sequence of the haplotypes disclosed herein are also described.
    Type: Application
    Filed: May 30, 2001
    Publication date: December 5, 2002
    Applicant: Genaissance Pharmaceuticals, Inc.
    Inventors: Alison E. Anastasio, Kevin Finkel, Beena Koshy, Helen Lee